Evaluation of the virological response to first -line HAART

Evaluation of the virological response to first -line HAART containing a ritonavir-boosted protease inhibitor (PI/r) among patients infected with HIV-1 subtypes CRF02_AG, A, C or F compared with subtype B infected patients

Por favor gira tu dispositivo para ver correctamente la web. Gracias